First Time Loading...

LianBio
NASDAQ:LIAN

Watchlist Manager
LianBio Logo
LianBio
NASDAQ:LIAN
Watchlist
Price: 0.319 USD -8.28% Market Closed
Updated: Jun 1, 2024

LianBio
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LianBio
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
LianBio
NASDAQ:LIAN
Cash Equivalents
$79.2m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$18.1B
CAGR 3-Years
23%
CAGR 5-Years
30%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$4.7B
CAGR 3-Years
5%
CAGR 5-Years
-23%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.7B
CAGR 3-Years
17%
CAGR 5-Years
6%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
26%
CAGR 10-Years
36%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2.6B
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
19%

See Also

What is LianBio's Cash Equivalents?
Cash Equivalents
79.2m USD

Based on the financial report for Dec 31, 2022, LianBio's Cash Equivalents amounts to 79.2m USD.

What is LianBio's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
22%

Over the last year, the Cash Equivalents growth was -65%. The average annual Cash Equivalents growth rates for LianBio have been 22% over the past three years .